Compare Globus Medical Inc. Class A Common Stock (GMED) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Toronto-Dominion Bank — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Toronto-Dominion Bank trades at $118 (market cap $192.46B). The key difference: Toronto-Dominion Bank is far larger — about 18.8× Globus Medical Inc. Class A Common Stock's market cap, and Toronto-Dominion Bank pays a 2.67% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Toronto-Dominion Bank for 85 Days on average.
| GMED | TD | |
|---|---|---|
Market Cap | $10.25B | $192.46B |
Volume | 1,059,528 | 2,419,463 |
Sector | Health | Financials |
52-Week High | $96.82 | $124.80 |
52-Week Low | $58.33 | $78.72 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $9.76B | $567.89B |
Dividend Yield | — | 2.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
TD stock trades at $117.95, up 1.25% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, with a net income margin of 24.88% and ROE of 13.64%. The company announced a $10 billion share buyback and a $108 billion commitment to Canadian infrastructure, signaling confidence in future growth. Analyst consensus is positive with 53% buy ratings and no sell recommendations.
The outlook is mixed; strong profitability and shareholder returns support upside, but technical indicators and volatile cash flows pose risks. Investors should weigh robust earnings against bearish momentum and macroeconomic uncertainties affecting the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
